ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Tianhuang formula ameliorates liver fibrosis by inhibiting CCL2-CCR2 axis and MAPK/NF-κB signaling pathway

Lan, Tian; Chen, Bo; Hu, Xianzhe; Cao, Jiafan; Chen, Shiyun; Ding, Xin; Li, Shengwen; Fu, Yanfang; Liu, Huanle; Luo, Duosheng; Rong, Xianglu; Guo, Jiao*广东药学院
Journal of Ethnopharmacology2024-3-1DOI: 10.1016/j.jep.2023.117516
9阅读
引用收藏
分享

摘要

Ethnopharmacological relevance: In the progression of chronic liver diseases, liver fibrosis is a reversible pathophysiologic event for liver diseases prognosis and risk of cirrhosis. Liver injury factors of different etiologies mediate this process. There is still a lack of effective medications for treating liver fibrosis. Additionally, the ameliorative effects of traditional herbs on liver fibrosis have been commonly reported. Tianhuang formula (THF) is a drug combination consisting of 2 traditional Chinese herbs, which has been showing significant improvement in metabolic liver diseases. However, the hepatoprotective effect and mechanism of THF in ameliorating liver fibrosis are still unclear.Aim of the study: This study aimed to investigate the effects of THF on carbon tetrachloride (CCl4)-induced and methionine-choline-deficient (MCD) diet-induced liver fibrosis model and to reveal the potential mechanisms. It can provide experimental evidence for THF as a therapeutic candidate for liver fibrosis.Materials and methods: In this study, CCl4-induced mice were treated with THF (80 mg/kg, 160 mg/kg) or Fuzheng Huayu (FZHY) capsules (4.8 g/kg) for 6 weeks. MCD-induced mice received the same doses of THF or FZHY for 4 weeks. FZHY is used as a comparative study in these two models. Following that, using kit reagents detected changes in relevant serum and liver biochemical indicators. Histological changes in mouse liver were measured by staining of H&E and Sirius Red. The markers expression of liver fibrosis and inflammation were detected using qRT-PCR, western blotting and immunohistochemical staining analysis. The potential regulatory mechanism of THF to ameliorate liver fibrosis was performed by RNA-sequencing analysis. Finally, the analysis results were verified by immunofluorescence co-staining, qRT-PCR and western blotting.Results: Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and hepatic triglyceride (TG) levels in CCl4 and MCD-induced liver fibrosis mice were significantly improved after THF treatment. Meanwhile, the expression of fibrosis and inflammation markers were significantly suppressed. Furthermore, THF downregulated the expression of the macrophage marker CD68. According to RNA-sequencing analysis, we found the CCL2-CCR2 axis and MAPK/NF-kappa B as the potential signaling pathway for THF against liver fibrosis.Conclusion: This study revealed that THF ameliorated liver injury, inflammation and fibrotic process by inhibiting CCL2-CCR2 axis and its downstream MAPK/NF-kappa B signaling pathway.

学科与关键词

关键词
Liver fibrosisTianhuang formulaInflammationCCL2-CCR2 axisMAPK/NF-kappa B
相关
加载中…
  • Effects and mechanisms of Xiaochaihu Tang against liver fibrosis: An integration of network pharmacology, molecular docking and experimental validation
    Wang, Shou-Jia; Ye, Wen; Li, Wan-Yi; Tian, Wen; Zhang, Meng; Sun, Yang; Feng, Ying-Da; Liu, Chen-Xu; Liu, Shao-Yuan; Cao, Wei; Meng, Jing-Ru*; Li, Xiao-Qiang*Journal of Ethnopharmacology, 2023, 303: 116053.被引 6
  • Antifibrotic mechanism of action based on the corresponding on Traditional Chinese Medicine formula-syndrome to explore Yin-Chen-Hao Decoction regulation of Kupffer cell function and MAPK pathways
    Cao Hongyan; Bian Yanqin; Wu Chao; Li Jianyuan; Liu Ping; Sun Mingyu世界中医药, 2015, (2).
  • Reversine and herbal Xiang-Sha-Liu-Jun-Zi decoction ameliorate thioacetamide-induced hepatic injury by regulating the RelA/NF-κB/caspase signaling pathway
    Mai, Zhen-Hao; Huang, Yu; Huang, Di; Huang, Zi-Sheng; He, Zhi-Xiang; Li, Pei-Lin; Zhang, Shuai; Weng, Jie-Feng; Gu, Wei-Li*Open Life Sciences, 2020, 15(1): 696-710.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Ethnopharmacology
发表日期
2024-03-01
卷期
第 321 卷
页码
117516
DOI
10.1016/j.jep.2023.117516
语言
ENGLISH
成果收录
SCIE
资助标注
Major Basic and Applied Basic Research Projects in Guangdong Province of China [2019B030302005]; National Natural Science Foundation of China [81830113, 82070590]

作者

  • L

    Lan, Tian (第一作者)

    guangdong pharmaceut univ

  • C

    Chen, Bo

    guangdong pharmaceut univ

查看全部 12 位作者收起作者
  • H

    Hu, Xianzhe

    guangdong pharmaceut univ

  • C

    Cao, Jiafan

    guangdong pharmaceut univ

  • C

    Chen, Shiyun

    guangdong pharmaceut univ

  • D

    Ding, Xin

    guangdong pharmaceut univ

  • L

    Li, Shengwen

    guangdong pharmaceut univ

  • F

    Fu, Yanfang

    guangdong pharmaceut univ

  • L

    Liu, Huanle

    guangdong pharmaceut univ

  • L

    Luo, Duosheng

    guangdong pharmaceut univ

  • R

    Rong, Xianglu

    guangdong pharmaceut univ

  • G

    Guo, Jiao (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417